Bile Duct Cancer Market Overview, Opportunities, Profile and Global Industry Analysis To 2027
Bile Duct Cancer Market Highlights
Bile
duct cancer is a rare type of neoplasm in which epithelial
cells of the bile duct are mutated and show epithelial differentiation. In
2014, according to the National Cancer Institute, there were an estimated
66,771 cases of intrahepatic bile duct cancer in the United States. Moreover,
the disease is expected to cause 28,920 deaths by the end of 2017 accounting
for 4.8% of all cancer deaths. Death rates have been rising on average 2.6%
each year over 2005-2014. Such an increasing prevalence of the bile duct cancer
will boost the market during the forecasted period. Moreover, rising healthcare
expenditures, increasing awareness for the disease and investments in the
R&D for treatment procedures is fuelling the market. However, high cost of
treatment and related side effects along with low healthcare expenditures in
the developing economies is expected restrain the market during the forecasted
period.
Segmentation
The
global bile duct cancer market is segmented on the basis of types, diagnosis,
treatment, and end user.
On the
basis of types, the market is segmented into intrahepatic, extrahepatic, and
others.
On the
basis of diagnosis, the market is segmented into blood tests, abdominal
imaging, surgery, and others. The diagnosis segment by abdominal imaging is sub
segmented into endoscopic retrograde cholangiopancreatography (ERCP),
percutaneous transhepatic cholangiography (PTC), magnetic resonance
cholangiopancreatography (MRCP), and others.
On the
basis of treatment, the market is segmented into chemotherapy, radiotherapy,
and others. The chemotherapy segment is sub segmented into 5-fluorouracil,
gemcitabine, cisplatin, and others.
On the basis of end users, the
market is segmented into hospital &clinics, academic institutes, research
organizations and others.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/4741
Regional Analysis
The
Americas dominates the global bile duct cancer market owing to a well-developed
healthcare sector. Apart from this, increasing number of patients, increasing
healthcare expenditure have boosted the growth of the market in the Americas.
According to the Centers for Disease Control and Prevention, U.S. health care
spending in 2015, reached $3.2 trillion or $9,990 per person which accounted
for 17.8% of the total GDP. Moreover, the presence of the global market leaders
like Pfizer Inc. and Bristol-Myers Squibb Company within the region fuels the
market growth during the forecasted period.
Europe
is the second largest bile duct cancer market. Availability of funds for
research, huge patient population and government support for research &
development drives the European market. Asia Pacific is the fastest growing
region for the market due to the presence of a huge patient population,
continuously developing economies like India and China, and presence of huge
opportunity in the market. According to Indian Brand Equity Fund, the per
capita healthcare expenditure in India is estimated to grow at a CAGR of 5%
during 2008-15 and reach USD 68.6 by 2015.
The
Middle East and Africa contribute the least in the growth of global bile duct
cancer market. The Middle East dominates the market for The Middle East and
Africa. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East
market. Africa holds the least share of the global bile duct cancer market due
to limited availability of medical facilities, poor economic condition and
rigid government policies
Key Players
The key
players for the global bile duct cancer market are Pfizer Inc. (U.S.), F.
Hoffmann-La Roche Ltd (Europe), Bristol-Myers Squibb Company (U.S.), Teva
Pharmaceutical Industries Ltd. (Middle East)
Eli
Lilly and Company. (U.S.), Sanofi (Europe), Fresenius Kabi AG (Europe), Mylan
N.V. (U.S.), and others.
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/bile-duct-cancer-market-4741
About
Market Research Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment